Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Watkins

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Nature Communications|September 6, 2022
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virusFangzhu Zhao, Zachary T Berndsen, Nuria Pedreño-Lopez, et al.
Science Translational Medicine|October 6, 2017
Neutralizing human monoclonal antibodies prevent Zika virus infection in macaquesDiogo M Magnani, Thomas F Rogers, Nathan Beutler, et al.
Journal of Virology|June 8, 2018
<i>Mamu-B*17</i><sup>+</sup> Rhesus Macaques Vaccinated with <i>env</i>, <i>vif</i>, and <i>nef</i> Manifest Early Control of SIVmac239 ReplicationMauricio A Martins, Damien C Tully, Núria Pedreño-Lopez, et al.
Journal of Virology|May 1, 2009
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challengeNancy A Wilson, Brandon F Keele, Jason S Reed, et al.
JCI Insight|July 15, 2025
Prophylactic and therapeutic neutralizing monoclonal antibody treatment prevents lethal yellow fever infectionLauren N Rust, Michael J Ricciardi, Savannah S Lutz, et al.
Journal of Virology|May 30, 2006
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239Nancy A Wilson, Jason Reed, Gnankang S Napoe, et al.
Antiviral Research|June 10, 2017
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus NetworkMatthew T Aliota, Leda Bassit, Shelton S Bradrick, et al.
Journal of Virology|November 25, 2005
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing GagDanilo R Casimiro, Fubao Wang, William A Schleif, et al.
Science Translational Medicine|March 29, 2023
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infectionMichael J Ricciardi, Lauren N Rust, Nuria Pedreño-Lopez, et al.
Nature Communications|April 26, 2018
Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaquesDiogo M Magnani, Thomas F Rogers, Nicholas J Maness, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Nature Communications|September 6, 2022
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virusFangzhu Zhao, Zachary T Berndsen, Nuria Pedreño-Lopez, et al.
Science Translational Medicine|October 6, 2017
Neutralizing human monoclonal antibodies prevent Zika virus infection in macaquesDiogo M Magnani, Thomas F Rogers, Nathan Beutler, et al.
Journal of Virology|June 8, 2018
<i>Mamu-B*17</i><sup>+</sup> Rhesus Macaques Vaccinated with <i>env</i>, <i>vif</i>, and <i>nef</i> Manifest Early Control of SIVmac239 ReplicationMauricio A Martins, Damien C Tully, Núria Pedreño-Lopez, et al.
Journal of Virology|May 1, 2009
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challengeNancy A Wilson, Brandon F Keele, Jason S Reed, et al.
JCI Insight|July 15, 2025
Prophylactic and therapeutic neutralizing monoclonal antibody treatment prevents lethal yellow fever infectionLauren N Rust, Michael J Ricciardi, Savannah S Lutz, et al.
Journal of Virology|May 30, 2006
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239Nancy A Wilson, Jason Reed, Gnankang S Napoe, et al.
Antiviral Research|June 10, 2017
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus NetworkMatthew T Aliota, Leda Bassit, Shelton S Bradrick, et al.
Journal of Virology|November 25, 2005
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing GagDanilo R Casimiro, Fubao Wang, William A Schleif, et al.
Science Translational Medicine|March 29, 2023
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infectionMichael J Ricciardi, Lauren N Rust, Nuria Pedreño-Lopez, et al.
Nature Communications|April 26, 2018
Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaquesDiogo M Magnani, Thomas F Rogers, Nicholas J Maness, et al.
Pageof 17